Date: | 23rd October 2024 |
Duration: | 1 hour 30 minutes |
Time: |
10:30 AM New Delhi 12:00 PM Bangkok, Hanoi 01:00 PM Singapore, Kuala Lumpur & Perth 03:00 PM Brisbane 04:00 PM Sydney, Melbourne & Canberra 06:00 PM Auckland |
Dr Ling Moi Lin
The hub of the catheter is a potential portal of entry for infection. Closed catheter access system is preferred to prevent central line-associated bloodstream infections (CLABSIs) to open systems. Catheter hubs, needleless connectors, and injection ports are to be disinfected before accessing. However, compliance may vary putting the patient at risk of infection. In the recent SHEA/IDSA/APIC Practice 2022 Recommendation: Strategies to prevent central line-associated bloodstream infections in acute-care hospitals, the use of an antiseptic-containing hub/connector cap/port protector to cover the connector is an additional approach that can be adopted to further reduce CLABSI.
Eliza Searcy
This presentation describes clinical challenges associated with catheter maintenance that can impact the bloodstream infection (BSI) risk. With a focus on the intraluminal route of contamination, challenges with IV access point disinfection as well as the role technology can play to support positive patient outcomes will be examined. Supporting clinical evidence is presented along with the 2024 Infusion Therapy Standards of Practice recommendation for the care and maintenance of IV access points.
MBBS, DP BACT, FRCPA, CPHQ
Director, Infection Prevention & Epidemiology
A/Prof Ling Moi Lin is the Past President of Asia Pacific Society of Infection Control (APSIC).
She received her medical education at the National University of Singapore. She obtained her postgraduate training in Microbiology at the Victoria University of Manchester, is a member of the Royal College of Pathologists of Australasia, and is a certified professional in healthcare quality (CPHQ).
She is currently the Director of Infection Prevention & Epidemiology at the Singapore General Hospital where she played a key role in the development and running of the Infection Prevention and Control program in the hospital. She is also the Director of Infection Prevention of SingHealth cluster.
She is the President of the Infection Control Association (Singapore) that was formed in 1999; She helped to set up the Healthcare Quality Society of Society in 2007 and is its founding President. Memberships to other professional societies include the Hospital Infection Society (UK) and fellow of the Society of Healthcare Epidemiology of America (SHEA).
BSN, RN, VA-BC
Global Application Engineer, CurosTM, St. Paul, MN
Eliza is a graduate of the University of Wisconsin, Eau Claire, Eliza Searcy, received her Bachelor of Science in Nursing degree in 2016. She has spent the last eight years of her nursing career working in multiple roles as a Vascular Access Specialist and becoming an expert in the use of ultrasound for vascular access device placement. Eliza continues to practice as a Pediatric Vascular Access, Registered Nurse and has a passion for education and improving patient care.
Eliza Searcy is currently a Senior Application Engineer at Solventum in the Medical Surgical Business working with the Vascular Access product portfolio. Her role at Solventum includes providing technical, clinical and product expertise both internally and externally, ensuring the safe and effective application of Solventum products in the hands of our customers through education, training, and communication.
Eliza Searcy is Vascular Access Board Certified, a member of the Association for Vascular Access, and a member of her local Minnesota Vascular Access Network.
An error has occurred while submitting. Please try again later...
The webcast link will be available 15 minutes from the start time. An email has also been sent to you with a link to the webcast.
Click the below links to save the webinar to your calendar.
![]() |
Outlook/iCal | ![]() |
Google Calendar |
The brands listed above are trademarks of 3M.